CSI Market
Sign In | Register

Rigel Pharmaceuticals Inc (RIGL) Annual Balance Sheets

Annual · GAAP · USD millions
Access RIGL quarterly Balance Sheets →
A period-by-period view of the balance sheet from Rigel Pharmaceuticals Inc to Dec 31 2021 helps clarify how Dec 31 2025's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent40.58
Short-term Investments, Total114.38
Cash & Short-term Investments154.00
Accounts receivable51.76
Inventories11.51
Other Current Assets0.00
Prepaid Expense And Other Assets Current21.94
Total Current Assets240.17
Equipment/Property/Plant Net0.00
Intangible Assets24.75
Tax Assets, Noncurrent0.00
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent248.68
Total Assets513.59
Liabilities
Accounts Payable, Current AC7.19
Employee-related Liabilities, Current AC11.91
Loans Payable, Current NO29.81
Other Liabilities, Current50.32
Taxes Payable0.00
Total Current Liabilities99.24
Long-term debt22.48
Total Long-term Debt22.48
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent0.40
Total Liabilities122.11
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock1,414.32
Retained Earnings / Accumulated Deficit-1,023.04
Accumulated Other Comprehensive Income0.00
Other Equity0.18
Common Stockholder's Equity391.48
Total Stockholder's Equity391.48
Liabilities & Stockholder's Equity513.59
4 historic quarters locked

Sign in to unlock the full Rigel Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Rigel Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001034842-26-000015

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License